Cipla Ltd.

₹1493.1

Cipla Ltd.

₹1493.1

₹1493.1

-6.8 (-0.45%) - 19 May 2025 01:04 PM

About Company

Cipla Limited, established in 1935, is a global pharmaceutical company with a strong commitment to make medicines accessible and affordable to those in need. The company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). Its product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS and various other key therapeutic segments. With a rich portfolio, the company is deepening its presence in the home markets of India, as well as South Africa, North America and other key regulated and emerging markets.

Market Cap. ₹ 121,138 Cr.
52 Week - High/Low ₹ 1,702/1,335
P/E Ratio 23.52
P/B Ratio 4.34
Enterprise Value ₹ 121,204 Cr.
ROE % 14.14
RSI Value 49.42
EMA 50 1493.21
EMA 200 1482.36
Market Cap. ₹ 121,138 Cr.
52 Week - High/Low ₹ 1,702/1,335
P/E Ratio 23.01
P/B Ratio 4.54
Enterprise Value ₹ 120,527 Cr.
ROE % 16.63
RSI Value 49.42
EMA 50 1493.21
EMA 200 1482.36

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.